✦ LIBER ✦

Debate: extended resection for pancreatic cancer; the affirmative case

✍ Scribed by Akimasa Nakao

Publisher: Springer Japan
Year: 2003
Tongue: English
Weight: 135 KB
Volume: 10
Category: Article
ISSN: 1868-6974
DOI: 10.1007/s10534-002-0801-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indications and Techniques of Extended R

Indications and Techniques of Extended Resection for Pancreatic Cancer

✍ Akimasa Nakao; Shin Takeda; Soichiro Inoue; Shuji Nomoto; Naohito Kanazumi; Hiro 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 826 KB

Long-term outcomes of extended radical r

Long-term outcomes of extended radical resection combined with intraoperative radiation therapy for pancreatic cancer

✍ Takamori, Hiroshi ;Hiraoka, Takehisa ;Kanemitsu, Keiichiro ;Tsuji, Tatsuya ;Tana 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 239 KB

Extended Radical Resection: The Choice f

Extended Radical Resection: The Choice for Locally Recurrent Rectal Cancer

✍ Alexander G. Heriot; Christopher M. Byrne; Peter Lee; Bruce Dobbs; Henry Tilney; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 171 KB

Combined resection of the pancreas and p

Combined resection of the pancreas and portal vein for pancreatic cancer

✍ Dr S. Takahashi; Y. Ogata; T. Tsuzuki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

Is the need for an arterial resection a

Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? a case-matched controlled study

✍ Philippe Bachellier; Edoardo Rosso; Ionut Lucescu; Elie Oussoultzoglou; Jacky Tr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

The case for routine use of adjuvant the

The case for routine use of adjuvant therapy in pancreatic cancer

✍ Eugene P. Kennedy; Charles J. Yeo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract Pancreatic cancer is a devastating disease with a poor prognosis for most patients. Surgical resection remains the cornerstone of treatment, providing the only realistic hope of long‐term survival. Even with optimal surgical management, 5‐year survival averages 15% to 20% for resectable